The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Duration of psychosis and outcome in first-episode schizophrenia
Abstract
OBJECTIVE: This study was undertaken to assess the potential effect of duration of untreated illness on outcome in a group of first-episode schizophrenic patients. METHOD: Seventy patients with schizophrenia diagnosed according to the Research Diagnostic Criteria entered the study and were followed for up to 3 years. All patients received standardized treatment and uniform assessments both during the acute phase of their illness and throughout the follow-up period. Outcome was measured in terms of time to remission of acute psychotic symptoms as well as degree of symptom remission. RESULTS: The mean duration of psychotic symptoms before initial treatment was 52 weeks, preceded by a substantial prepsychotic period. According to survival analysis, duration of illness before treatment was found to be significantly associated with time to remission as well as with level of remission. The effect of duration of illness on outcome remained significant when diagnosis and gender variables, themselves associated with outcome, were controlled in a regression analysis. Duration of illness was not correlated with age at onset, mode of onset, premorbid adjustment, or severity of illness at entry into the study. CONCLUSIONS: Duration of psychosis before treatment may be an important predictor of outcome in first-episode schizophrenia. Acute psychotic symptoms could reflect an active morbid process which, if not ameliorated by neuroleptic drug treatment, may result in lasting morbidity. Further implications of these findings are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Social class and mental illness: Community study.
Hollingshead, A. B., & Redlich, F. C. (1958) · John Wiley & Sons, Inc. eBooks · doi:10.1037/10645-000 · Cited by 3,738
Social Class and Mental Illness
Hunt, R. G., Hollingshead, A. B., & Redlich, F. C. (1959) · The American Journal of Psychology · doi:10.2307/1420236 · Cited by 3,282
(2008) · The Concise Encyclopedia of Statistics · doi:10.1007/978-0-387-32833-1_5 · Cited by 2,670
Plackett, R. L., & Cox, D. R. (1971) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344247 · Cited by 2,264
ECDEU Assessment Manual: (591322011-001)
Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896
Measurement of Premorbid Adjustment in Chronic Schizophrenia
Cannon-Spoor, H. E., Potkin, S. G., & Wyatt, R. J. (1982) · Schizophrenia Bulletin · doi:10.1093/schbul/8.3.470 · Cited by 1,201
Neuroleptics and the Natural Course of Schizophrenia
Wyatt, R. J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.325 · Cited by 787
Stimulants : neurochemical, behavioral, and clinical perspectives
Creese, I. (1983) · Raven Press eBooks · Cited by 698
Prediction of Outcome in Schizophrenia: III. Five-Yearn Outcome and Its Predictors
Strauss, J. S. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770140049005 · Cited by 521
II. A Randomised Controlled Trial of Prophylactic Neuroleptic Treatment
Crow, T. J., MacMillan, J. F., Johnson, A. L., & Johnstone, E. C. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.148.2.120 · Cited by 491
Cited by
(2009) · Cited by 2,013
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Marshall, M., Lewis, S., Lockwood, A., Drake, R., Jones, P., & Croudace, T. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.975 · Cited by 1,593
Wang, P. S., Berglund, P., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.603 · Cited by 1,325
Perkins, D. O., Gu, H., Boteva, K., & Lieberman, J. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1785 · Cited by 1,346
The Prodromal Phase of First-episode Psychosis: Past and Current Conceptualizations
Yung, A. R., & McGorry, P. D. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.2.353 · Cited by 1,168
Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group
Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S. M., McFarlane, C. A., Hallgren, M., & McGorry, P. D. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00167-6 · Cited by 1,136
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,027
EPPIC: An Evolving System of Early Detection and Optimal Management
McGorry, P. D., Edwards, J., Mihalopoulos, C., Harrigan, S. M., & Jackson, H. J. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.2.305 · Cited by 937
Monitoring and Care of Young People at Incipient Risk of Psychosis
Yung, A. R., McGorry, P. D., McFarlane, C. A., Jackson, H. J., Patton, G. C., & Rakkar, A. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.2.283 · Cited by 772
Symptom Assessment in Schizophrenic Prodromal States
Miller, T. J., McGlashan, T. H., Woods, S. W., Stein, K., Driesen, N., Corcoran, C. M., Hoffman, R., & Davidson, L. (1999) · Psychiatric Quarterly · doi:10.1023/a:1022034115078 · Cited by 642
Prediction of psychosis: A step towards indicated prevention of schizophrenia
Yung, A. R., Phillips, L. J., McGorry, P. D., McFarlane, C. A., Francey, S., Harrigan, S., Patton, G. C., & Jackson, H. J. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297602 · Cited by 630
Craig, T. K. J., Garety, P., Power, P., Rahaman, N., Colbert, S., Fornells-Ambrojo, M., & Dunn, G. (2004) · BMJ · doi:10.1136/bmj.38246.594873.7c · Cited by 615
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Vulnerability to psychopathology: A biosocial model.
Zuckerman, M. (1999) · American Psychological Association eBooks · doi:10.1037/10316-000 · Cited by 601
Lieberman, J. A., Perkins, D., Belger, A., Chakos, M., Jarskog, F., Boteva, K., & Gilmore, J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01303-8 · Cited by 593
Behavioral and Intellectual Markers for Schizophrenia in Apparently Healthy Male Adolescents
Davidson, M., Reichenberg, A., Rabinowitz, J., Weiser, M., Kaplan, Z., & Mark, M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1328 · Cited by 582
The Glutamatergic Dysfunction Hypothesis for Schizophrenia
Coyle, J. T. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609017192 · Cited by 568
Longitudinal study of brain morphology in first episode schizophrenia
Lieberman, J., Chakos, M., Wu, H., Alvir, J., Hoffman, E., Robinson, D., & Bilder, R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01067-8 · Cited by 554
The Initial Prodrome in Psychosis: Descriptive and Qualitative Aspects
Yung, A. R., & McGorry, P. D. (1996) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679609062654 · Cited by 506
Operational criteria and factors related to recovery from schizophrenia
Liberman, R. P., Kopelowicz, A., Ventura, J., & Gutkind, D. (2002) · International Review of Psychiatry · doi:10.1080/0954026021000016905 · Cited by 495
Treatment-Resistant Schizophrenia - The Role of Clozapine
Meltzer, H. Y. (1997) · Current Medical Research and Opinion · doi:10.1185/03007999709113338 · Cited by 491
Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective
Lieberman, J. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00147-x · Cited by 483
Duration of untreated psychosis: a critical examination of the concept and its importance
NORMAN, R. M. G., & MALLA, A. K. (2001) · Psychological Medicine · doi:10.1017/s0033291701003488 · Cited by 482
Predictors of Treatment Response From a First Episode of Schizophrenia or Schizoaffective Disorder
Robinson, D. G., Woerner, M. G., Alvir, J. M. J., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D., Bilder, R., Goldman, R., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.544 · Cited by 466
Moller, P., & Husby, R. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033442 · Cited by 464
Time Course and Biologic Correlates of Treatment Response in First-Episode Schizophrenia
Lieberman, J. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820170047006 · Cited by 442
Reducing the Duration of Untreated First-Episode Psychosis: Effects on Clinical Presentation
Melle, I., Larsen, T. K., Haahr, U., Friis, S., Johannessen, J. O., Opjordsmoen, S., Simonsen, E., Rund, B. R., Vaglum, P., & McGlashan, T. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.2.143 · Cited by 440
Häfner, H., & an der Heiden, W. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200204 · Cited by 436
Häfner, H., Löffler, W., Maurer, K., Hambrecht, M., & Heiden, W. A. D. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb10831.x · Cited by 430
Early Detection and Intervention With Schizophrenia: Rationale
McGlashan, T. H., & Johannessen, J. O. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.2.201 · Cited by 419
Schizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 409
Seikkula, J., Aaltonen, J., Alakare, B., Haarakangas, K., Keränen, J., & Lehtinen, K. (2006) · Psychotherapy Research · doi:10.1080/10503300500268490 · Cited by 408
Levkovitz, Y., Mendlovich, S., Riwkes, S., Braw, Y., Levkovitch-Verbin, H., Gal, G., Fennig, S., Treves, I., & Kron, S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04666yel · Cited by 387
“We focused on patients in the early stage of schizophrenia in light of findings indicating that early pharmacologic intervention could improve the course of the disorder.(42) In addition, we aimed to reduce the deterioration that occurs primarily in the early stages of the disorder (generally confined to the first 5 y…”
BackgroundSchizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Neural development, cell-cell signaling, and the “two-hit” hypothesis of schizophrenia
Maynard, T. M., Sikich, L., Lieberman, J. A., & LaMantia, A.-S. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006887 · Cited by 383
Self-citation(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1744 · Cited by 382
Lieberman, J. A., Girgis, R. R., Brucato, G., Moore, H., Provenzano, F., Kegeles, L., Javitt, D., Kantrowitz, J., Wall, M. M., Corcoran, C. M., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.249 · Cited by 376
Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?
McGlashan, T. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00084-0 · Cited by 374
Meyer, U., Feldon, J., & Fatemi, S. H. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.05.001 · Cited by 373
Epidemiology-driven neurodevelopmental animal models of schizophrenia
Meyer, U., & Feldon, J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.018 · Cited by 372
Recovery From Schizophrenia: A Concept in Search of Research
Liberman, R. P., & Kopelowicz, A. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.6.735 · Cited by 370
Laruelle, M. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00054-5 · Cited by 358
Barnes, T. R., & the Schizophrenia Consensus Group of the British Association for Psychopharmacology (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 356
Causes and consequences of duration of untreated psychosis in schizophrenia
Drake, R. J., Haley, C. J., Akhtar, S., & Lewis, S. W. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.6.511 · Cited by 346
Lieberman, J. A., Phillips, M., Gu, H., Stroup, S., Zhang, P., Kong, L., Ji, Z., Koch, G., & Hamer, R. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300157 · Cited by 345
Lieberman, J. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00045-6 · Cited by 333
A systematic review of longitudinal outcome studies of first-episode psychosis
MENEZES, N. M., ARENOVICH, T., & ZIPURSKY, R. B. (2006) · Psychological Medicine · doi:10.1017/s0033291706007951 · Cited by 333
A scientific agenda for the concept of recovery as it applies to schizophrenia
Silverstein, S. M., & Bellack, A. S. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2008.03.004 · Cited by 331
Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H.-J., WFSBP Task Force on Treatment Guide, Falkai, P., Wobrock, T., Lieberman, J., et al. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970500483177 · Cited by 331
Causes and Consequences of the Gender Difference in Age at Onset of Schizophrenia
Hafner, H., an der Heiden, W., Behrens, S., Gattaz, W. F., Hambrecht, M., Loffler, W., Maurer, K., Munk-Jorgensen, P., Nowotny, B., Riecher-Rossler, A., et al. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033317 · Cited by 331
First-episode Schizophrenia: I. Early Course Parameters
Larsen, T. K., McGlashan, T. H., & Moe, L. C. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.2.241 · Cited by 323
Two-Year Outcome in First-Episode Schizophrenia: Predictive Value of Symptoms for Quality of Life
Ho, B.-C., Nopoulos, P., Flaum, M., Arndt, S., & Andreasen, N. C. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1196 · Cited by 312
The Varied Outcomes of Schizophrenia
Davidson, L., & McGlashan, T. H. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200105 · Cited by 308
Early Intervention in Psychosis: Obvious, Effective, Overdue
McGorry, P. D. (2015) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000284 · Cited by 289
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
Demjaha, A., Lappin, J. M., Stahl, D., Patel, M. X., MacCabe, J. H., Howes, O. D., Heslin, M., Reininghaus, U. A., Donoghue, K., Lomas, B., et al. (2017) · Psychological Medicine · doi:10.1017/s0033291717000435 · Cited by 289
First-Episode Psychosis: Psychopathology, Quality of Life, and Functional Outcome
Malla, A. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi031 · Cited by 288
Santesteban-Echarri, O., Paino, M., Rice, S., González-Blanch, C., McGorry, P., Gleeson, J., & Alvarez-Jimenez, M. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.09.007 · Cited by 268
Development, disease and degeneration in schizophrenia: a unitary pathophysiological model
Keshavan, M. S. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00033-3 · Cited by 272
Comorbid substance use and age at onset of schizophrenia
Barnes, T. R. E., Mutsatsa, S. H., Hutton, S. B., Watt, H. C., & Joyce, E. M. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.104.007237 · Cited by 271
Hopper, K., & Wanderling, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033498 · Cited by 270
Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H.-J., WFSBP Task Force on Treatment Guidelines for Schizophrenia, Falkai, P., Wobrock, T., Lieberman, J., et al. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510030090 · Cited by 269
Delays in Initial Treatment Contact after First Onset of a Mental Disorder
Wang, P. S., Berglund, P. A., Olfson, M., & Kessler, R. C. (2004) · Health Services Research · doi:10.1111/j.1475-6773.2004.00234.x · Cited by 249
Ho, B.-C., Andreasen, N. C., Flaum, M., Nopoulos, P., & Miller, D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.808 · Cited by 259
Clinical predictors of therapeutic response to antipsychotics in schizophrenia
Carbon, M., & Correll, C. U. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/mcarbon · Cited by 257
Marital and Labor Market Status in the Long Run in Schizophrenia
Agerbo, E., Byrne, M., Eaton, W. W., & Mortensen, P. B. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.28 · Cited by 254
Schizophrenia--Time to Commit to Policy Change
Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R. E., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu006 · Cited by 214
Chidhood precursors of psychiosis as clues to its evolutionary orgins
Crow, T. J., Done, D. J., & Sacker, A. (1995) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190732 · Cited by 204
Prodromal interventions for schizophrenia vulnerability: the risks of being “at risk”
Corcoran, C., Malaspina, D., & Hercher, L. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.05.021 · Cited by 183
Bonner-Jackson, A., Grossman, L. S., Harrow, M., & Rosen, C. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.02.005 · Cited by 81
First-episode psychosis in the military: A comparative study of prodromal symptoms
Tan, H.-Y., Ang, Y.-G., Tan, H.-Y., & Ang, Y.-G. (2001) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2001.00912.x · Cited by 80
Toward a world consensus on prevention of schizophrenia
Van Os, J., & Delespaul, P. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.1/jvanos · Cited by 75
Jablensky, A. (2003) · Schizophrenia · doi:10.1002/9780470987353.ch12 · Cited by 59
Early psychosis treatment in an integrated model within an adult mental health service
Petrakis, M., Penno, S., Oxley, J., Bloom, H., & Castle, D. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.03.004 · Cited by 26
Mathalon, D. H., Sullivan, E. V., Lim, K. O., & Pfefferbaum, A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.2.148
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1992-09-01
- Volume
- 149
- Issue
- 9
- Pages
- 1183-1188
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2394641975
- Cited by
- 880
- References
- 30
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.